BACKGROUND & AIMS:
Two licensed rotavirus vaccines are funded under the Australian National Immunisation Program (NIP) for all children born from 1 May 2007. We examined the impact of RIX4414 (Rotarix™, GlaxoSmithKline Biologicals) vaccination on rotavirus gastroenteritis...(more)
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
Powered by MULTIWEBCAST Technologies. MULTIWEBCAST PLATFORM Version 4.1000. All rights reserved.